Market Closed -
OTC Markets
02:45:54 2024-04-15 pm EDT
5-day change
1st Jan Change
0.000001
USD
0.00%
0.00%
0.00%
EVIO, Inc. Announces Address Change
January 18, 2019 at 09:29 am EST
In conjunction with the closure of the Bend office, EVIO, Inc. has relocated its corporate headquarters to 2340 W. Horizon Ridge Pkwy, Suite 120, Henderson, NV 89052.
DigiPath, Inc. cancelled the acquisition of a controlling stake in C3 Labs, LLC from EVIO, Inc..
22-03-10
CI
EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC
22-01-04
CI
DigiPath, Inc. signed letter of intent to acquire a controlling stake in C3 Labs, LLC from EVIO, Inc..
21-12-06
CI
Framework announced that it has received $2 million in funding from EVIO, Inc., Atomico Investment Holdings Limited, Ada Ventures Limited, Learn Capital, LLC, and other investors
21-11-10
CI
EVIO, Inc. Announces Diversification into Blockchain
21-11-02
CI
EVIO, Inc. entered into a letter of intent to acquire Leading Edge Pharms, Inc.
21-07-11
CI
EVIO, Inc. announced that it has received $0.157 million in funding
21-02-03
CI
EVIO, Inc. Announces Executive Changes
21-01-04
CI
EVIO, Inc. Announces Executive Changes
21-01-04
CI
Steep Hill, Inc. completed the acquisition of unknown minority stake in C3 Labs, LLC from EVIO, Inc..
20-09-29
CI
Evio, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2020
20-09-09
CI
EVIO, Inc. Announces Executive Changes
20-07-10
CI
Steep Hill Labs, Inc. entered into non-binding Letter of Intent to acquire 49% stake in C3 Labs, LLC from EVIO, Inc..
20-07-05
CI
Evio, Inc. Reports Earnings Results for the Full Year Ended September 30, 2019
20-05-20
CI
EVIO Inc. Labs Now Offers Vitamin E Acetate Testing
19-11-20
CI
Evio, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2019
19-11-15
CI
Evio, Inc. Labs Expands Oregon Testing Capability
19-11-12
CI
Evio, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2019
19-10-18
CI
Evio, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2018
19-09-30
CI
Evio, Inc. Reports Earnings Results for the Full Year Ended September 30, 2018
19-08-19
CI
EVIO, Inc. Engages in Strategic Partnership to Launch EVIO Labs Costa Mesa
19-05-08
CI
EVIO, Inc. announced a financing transaction
19-04-09
CI
EVIO, Inc. Announces Address Change
19-01-18
CI
Oregon Liquor Control Commission Accepts Voluntary Surrender of Evio, Inc. Laboratory Testing Licenses
19-01-18
CI
EVIO, Inc. Announces Executive Changes
19-01-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.
More about the company
1st Jan change
Capi.
0.00% 19.19K +14.61% 17.2B 0.00% 6.8B -12.39% 2.88B -11.15% 2.72B -31.21% 1.74B +5.00% 1.25B -7.31% 1.06B -6.67% 870M -4.08% 794M
Testing Laboratories
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
EVIO, INC. 
